SMLR
Semler Scientific, Inc. (SMLR) 10Y Growth Potential Analysis (2026)
Revenue Growth Drivers
Revenue growth capacity is constrained by weak current profitability and negative ROIC, which limits reinvestment versus stronger-scaled peers.
High capex intensity relative to revenue suggests expansion requires heavy ongoing spending, reducing compounding efficiency versus asset-light peers.
No five-year revenue CAGR is provided, so long-term growth evidence is limited and weaker than peers with demonstrated multi-year expansion.
Elevated leverage and negative interest coverage can restrict funding flexibility, making sustained revenue scaling harder than for financially stronger peers.
Market Tailwinds
The available metrics do not show a quantified structural demand tailwind, leaving growth support less visible than for peers with proven category expansion.
Revenue scalability appears more dependent on execution and capital deployment than on a clearly evidenced market expansion advantage.
Absence of segment concentration data limits proof of durable share gains, which weakens relative growth visibility versus peers with clearer demand capture.
Compared with faster-scaling peers, the current data imply a more mature or constrained demand backdrop rather than a strong multi-year tailwind.
Scalability Expansion
Capex to revenue near 9.8% indicates expansion is possible, but the capital burden reduces scalability versus peers with lower reinvestment needs.
Cash conversion cycle above 600 days signals working-capital drag, which slows internal funding of growth and weakens compounding efficiency.
Negative free cash flow yield suggests current operations are not yet self-funding, limiting the pace of scalable expansion versus cash-generative peers.
Without evidence of improving operating leverage, the company’s ability to compound revenue remains below stronger platform businesses.
Constraints Limitations
Negative ROIC indicates incremental capital has not yet translated into value-creating growth, which structurally caps long-term compounding.
Net debt to EBITDA above 3.0 and negative interest coverage constrain financial flexibility, limiting expansion capacity versus less levered peers.
Very high cash conversion cycle ties up capital in operations, creating a persistent scaling drag rather than a temporary execution issue.
The lack of disclosed multi-year growth metrics prevents evidence of durable scaling, leaving the long-term growth case weaker than peers with proven trajectories.
Overall Score
SMLR shows viable but constrained long-term growth capacity, with capital intensity, weak returns, and leverage limiting scalability versus stronger peers.
Score Driver: Capital Intensity
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Semler Scientific, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

